Earnings Feed
Start Free
Home/Filings/4/0001181431-13-057000
4//SEC Filing

HARVARD BIOSCIENCE INC 4

Accession 0001181431-13-057000

$HBIOCIK 0001123494operating
View on SEC.govCompany Profile

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 6:20 PM ET

Size

32.5 KB

Accession

0001181431-13-057000

Insider Transaction Report

Form 4
Period: 2013-11-01
HARVARD BIOSCIENCE INCHBIO
HARTE NEAL J
Director
Transactions
  • Other

    Stock option (right to buy)

    2013-11-01+5,720→ 23,720 total
    Exercise: $2.28Exp: 2019-05-21→ Common Stock, par value $0.01 per share (5,720 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+5,113→ 21,213 total
    Exercise: $2.56Exp: 2022-06-01→ Common Stock, par value $0.01 per share (5,113 underlying)
  • Other

    Common Stock

    2013-11-01+3,646→ 20,955 total
  • Other

    Stock option (right to buy)

    2013-11-01+3,379→ 13,379 total
    Exercise: $6.57Exp: 2014-02-20→ Common Stock, par value $0.01 per share (3,379 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+3,616→ 15,016 total
    Exercise: $3.64Exp: 2023-05-31→ Common Stock, par value $0.01 per share (3,616 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+1,589→ 6,589 total
    Exercise: $3.01Exp: 2016-05-25→ Common Stock, par value $0.01 per share (1,589 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+803→ 3,303 total
    Exercise: $3.32Exp: 2014-06-04→ Common Stock, par value $0.01 per share (803 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+3,317→ 13,317 total
    Exercise: $3.82Exp: 2014-06-21→ Common Stock, par value $0.01 per share (3,317 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+6,352→ 26,352 total
    Exercise: $2.15Exp: 2015-05-26→ Common Stock, par value $0.01 per share (6,352 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+1,603→ 6,603 total
    Exercise: $3.71Exp: 2017-05-24→ Common Stock, par value $0.01 per share (1,603 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+1,586→ 6,586 total
    Exercise: $3.41Exp: 2018-05-22→ Common Stock, par value $0.01 per share (1,586 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+5,445→ 22,545 total
    Exercise: $2.59Exp: 2020-06-04→ Common Stock, par value $0.01 per share (5,445 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+5,707→ 23,707 total
    Exercise: $4.04Exp: 2021-06-02→ Common Stock, par value $0.01 per share (5,707 underlying)
Footnotes (14)
  • [F1]These additional options and restricted stock units were acquired by the Reporting Person in connection with the adjustment to the existing options and restricted stock units held by the Reporting Person and required in connection with the spin-off of Harvard Apparatus Regenerative Technology, Inc. by the Issuer. As part of such required adjustment relating to the spin-off, the exercise price of the options underlying these adjustment option grants was also reset to the exercise price of these adjustment grants to reflect the impact of the spin-off. The share amounts and exercise prices of the adjusted options and restricted stock units were set in a manner to ensure the intrinsic value held by the Reporting Person pertaining to the existing award was maintained immediately following the spin-off. In addition to these adjustments, to maintain such intrinsic value, equity awards issued by Harvard Apparatus Regenerative Technology, Inc. were also granted to the Reporting Person.
  • [F10]The option shares vested in three equal installments on May 21, 2010, 2011 and 2012.
  • [F11]The option shares vested in three equal installments on June 4, 2011, 2012 and 2013.
  • [F12]The option shares vest in three equal installments on June 2, 2012, 2013 and 2014.
  • [F13]The option shares vest in three equal installments on June 1, 2013, 2014 and 2015.
  • [F14]The options shall fully vest on May 31, 2014.
  • [F2]Includes (a) an adjusted deferred stock award of 7,777 restricted stock units which shall fully vest on May 31, 2014; and (b) an adjusted deferred stock award of 7,377 restricted stock units which vest in equal installments on June 1, 2014 and June 1, 2015; and (c) 5,801 shares of common stock held by the Reporting Person.
  • [F3]The option shares vested in three equal installments on each of February 20, 2005, 2006 and 2007.
  • [F4]The option shares vested in three equal installments on May 25, 2007, 2008 and 2009.
  • [F5]The option shares vested in three equal installments on June 4, 2005, 2006 and 2007.
  • [F6]The option shares vested in three equal installments on June 21, 2005, 2006 and 2007.
  • [F7]The option shares vested in three equal installments on May 26, 2006, 2007 and 2008.
  • [F8]The option shares vested in three equal installments on May 24, 2008, 2009 and 2010.
  • [F9]The option shares vested in three equal installments on May 22, 2009, 2010 and 2011.

Documents

1 file

Issuer

HARVARD BIOSCIENCE INC

CIK 0001123494

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001123494

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:20 PM ET
Size
32.5 KB
View on SEC.gov